R Burcelin Selected Research

Lipids

4/2013	Incretins: what is known, new and controversial in 2013?
5/2009	n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Burcelin Research Topics

Disease

13	Insulin Resistance 02/2016 - 12/2000
10	Obesity 01/2017 - 03/2001
6	Type 2 Diabetes Mellitus (MODY) 01/2017 - 03/2006
6	Inflammation (Inflammations) 06/2015 - 05/2009
4	Hypoglycemia (Reactive Hypoglycemia) 08/2001 - 08/2000
3	Weight Loss (Weight Reduction) 01/2017 - 11/2012
3	Body Weight (Weight, Body) 02/2016 - 05/2009
2	Overweight 01/2017 - 02/2016
2	Hypertension (High Blood Pressure) 01/2017 - 07/2001
2	Weight Gain 06/2015 - 12/2014
2	Metabolic Diseases (Metabolic Disease) 06/2014 - 01/2013
2	Hyperinsulinism (Hyperinsulinemia) 07/2001 - 03/2001
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2016
1	Neoplasms (Cancer) 05/2014
1	Heart Failure 04/2013
1	Fatty Liver 01/2011
1	Hypertrophy 05/2009
1	Body Weight Changes 12/2007
1	Fibrosis (Cirrhosis) 06/2007
1	Gram-Negative Bacterial Infections 06/2007
1	Hyperlipidemias (Hyperlipidemia) 07/2001
1	Renovascular Hypertension (Goldblatt Syndrome) 07/2001
1	Hyperphagia (Overeating) 03/2001
1	Glycosuria 08/2000
1	Hyperplasia 04/2000

Drug/Important Bio-Agent (IBA)

16	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 04/2000
10	Insulin (Novolin)FDA Link 11/2012 - 08/2000
4	GlycogenIBA 05/2009 - 04/2000
3	LipopolysaccharidesIBA 12/2014 - 06/2007
2	CholesterolIBA 01/2017 - 07/2012
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2017 - 11/2012
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2017 - 04/2013
2	Proteins (Proteins, Gene)FDA Link 06/2015 - 05/2014
2	Triglycerides (Triacylglycerol)IBA 06/2014 - 06/2007
2	Metformin (Glucophage)FDA LinkGeneric 05/2014 - 11/2012
2	LipidsIBA 04/2013 - 05/2009
2	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2013 - 08/2001
2	LeptinIBA 01/2011 - 03/2001
2	Glucagon (Glukagon)FDA Link 02/2008 - 08/2000
2	Adrenergic Agents (Adrenergic Drugs)IBA 12/2007 - 02/2003
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2000 - 10/2000
1	Liraglutide FDA Link 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2016
1	Blood Glucose (Blood Sugar)IBA 02/2016
1	Abatacept (Orencia)FDA Link 06/2015
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2014
1	Biomarkers (Surrogate Marker)IBA 05/2014
1	Dipeptidyl-Peptidase IV InhibitorsIBA 04/2013
1	Neuroprotective AgentsIBA 04/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2013
1	lipopolysaccharide-binding proteinIBA 11/2012
1	ImmunosorbentsIBA 11/2012
1	EnzymesIBA 11/2012
1	Transcription Factor CHOPIBA 04/2012
1	Ribosomal DNA (rDNA)IBA 12/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2011
1	Mitogen-Activated Protein Kinase 3IBA 01/2011
1	PPAR gammaIBA 05/2009
1	Rosiglitazone (Avandia)FDA Link 05/2009
1	AdiponectinIBA 05/2009
1	ThiazolidinedionesIBA 05/2009
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2009
1	CeramidesIBA 05/2009
1	Hormones (Hormone)IBA 02/2008
1	Phentolamine (Z-Max)FDA LinkGeneric 12/2007
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2007
1	benzylamineIBA 12/2007
1	Drinking WaterIBA 12/2007
1	Toll-Like Receptor 4IBA 06/2007
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2001

Therapy/Procedure

2	Therapeutics 02/2016 - 04/2013
1	Bariatric Surgery 04/2013
1	Precision Medicine 01/2013
1	Complementary Therapies (Alternative Medicine) 05/2009
1	Surgical Instruments (Clip) 07/2001